Congressman Chris Collins Announces $750,000 in Federal Funding for Neurovascular Diagnostics, Inc.
Clarence, NY – Congressman Chris Collins (NY-27) announced $750,000 in federal funding for Neurovascular Diagnostics, Inc. in Buffalo. This grant was awarded through the National Science Foundation’s Industrial Innovation and Partnerships (IIP) program which invests in high-tech small businesses to transform discoveries into innovative commercial technologies.
Partnered with the University of Buffalo, Neurovascular Diagnostics, Inc. is developing low-cost blood test for detecting unruptured brain aneurysms. Currently, brain aneurysms are identified using imaging of the brain that is expensive and time consuming.
“Patients can show no symptoms that an unruptured aneurysm is present which is why I applaud the Neurovascular Diagnostics, Inc. for developing a way to lower the cost for detecting this,”said Congressman Collins. “This grant funding will allow researchers to expand their studies and accelerate creating adequate screening tools to identify this deadly medical condition.”
This grant funding will be used for validating and testing a novel blood-based diagnostic to detect unruptured brain aneurysms in asymptomatic patients. In the U.S., approximately 2-5% of the population (about 6-17 million Americans) harbors an unruptured brain aneurysm. Since aneurysms are largely asymptomatic, these individuals are unaware of the potential danger they are in.